Don't Try This At Home: Zazzle-Created EstroGel Promo Card Fizzles With FDA
This article was originally published in The Pink Sheet Daily
Executive Summary
Low-grade sales piece touting cost savings with Ascend Therapeutics’ product lacks risk information; it is just the seventh Rx citation by FDA this year.
You may also be interested in...
Ascend’s EstroGel Promotion Misrepresents Efficacy Compared To Other Products, US FDA Says
Professional sell sheet falsely suggests estradiol gel contains lowest effective dose of estrogen compared to other estrogen products, OPDP says in fourth “untitled” letter of 2018.
Ascend Therapeutics Inc.
Ascend Therapeutics aims to develop two non-hormone drugs delivered via hydroalcoholic gels that penetrate quickly into the skin.
Companies Reveal Hurdles In Providing Drugs Via Expanded Access Programs
GSK, Stealth BioTherapeutics and Blueprint Medicines discuss the difficulties getting participation of physicians, the excessive cost of expanded access, and whether physicians should report research data.